HHS announced Wednesday that it is working with AstraZeneca to make available at least 300 million doses of an investigational coronavirus vaccine, aiming to deliver the first doses in October. The agreement between the Biomedical Advanced Research and Development Authority (BARDA), which is part of the HHS Office of the Assistant Secretary for Preparedness and Response, and AstraZeneca, will accelerate the development and manufacturing of the vaccine candidate, known as AZD1222, to start Phase III clinical studies in the United States this summer.APhA
Friday, May 22, 2020
Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October
HHS announced Wednesday that it is working with AstraZeneca to make available at least 300 million doses of an investigational coronavirus vaccine, aiming to deliver the first doses in October. The agreement between the Biomedical Advanced Research and Development Authority (BARDA), which is part of the HHS Office of the Assistant Secretary for Preparedness and Response, and AstraZeneca, will accelerate the development and manufacturing of the vaccine candidate, known as AZD1222, to start Phase III clinical studies in the United States this summer.APhA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment